Great to see you back again Bigpharma. I think it was you that mentioned the "sink effect" of trying to use pyc cell penetrating tech in humans rather than mice. I thought that was why targeting the eye was such a good move. Surely that limits the sink effect to a huge degree if only injecting onto the eye? Obviously still needs to be proven in real human trials but they seem to have shown good progress to date in petri dishes with human derived samples?
Great to see you back again Bigpharma. I think it was you that...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
0.020(1.59%) |
Mkt cap ! $743.6M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.28 | $1.24 | $46.67K | 37.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15857 | $1.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |